- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on Apr 21, 2026
3760256960CELLIS84CELLIS C2030E is an EU MDR-regulated medical device registered in EUDAMED. It is classified as Class III. Manufactured by MECCELLIS BIOTECH. Placed on the EU market in France. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
037602569600423760256960CELLIS84CELLIS C2030E(01)03760256960042
The compliance carrier: encodes the device identifier plus the production identifiers (lot, serial, dates) registered for this device.
European Medical Device Nomenclature — the EU product classification assigned to this device.
P900299SURGICAL MESHES - OTHER5 warnings recorded — scroll inside the panel to see all entries.
CW010CW267CW009CW001CW007Primary placement in France; available across 32 countries total.
| Country | On market since | Until |
|---|---|---|
| FrancePrimary placement | Still on market | |
| Austria | Still on market | |
| Belgium | Still on market | |
| Bulgaria | Still on market | |
| Cyprus | Still on market | |
| Czechia | Still on market | |
| Germany | Still on market | |
| Denmark | Still on market | |
| Estonia | Still on market | |
| EL | Still on market | |
| Spain | Still on market | |
| Finland | Still on market | |
| Croatia | Still on market | |
| Hungary | Still on market | |
| Ireland | Still on market | |
| Iceland | Still on market | |
| Italy | Still on market | |
| Liechtenstein | Still on market | |
| Lithuania | Still on market | |
| Luxembourg | Still on market | |
| Latvia | Still on market | |
| Malta | Still on market | |
| Netherlands | Still on market | |
| Norway | Still on market | |
| Poland | Still on market | |
| Portugal | Still on market | |
| Romania | Still on market | |
| Sweden | Still on market | |
| Slovenia | Still on market | |
| Slovakia | Still on market | |
| Türkiye | Still on market | |
| XI | Still on market |
FR-MF-000002452Certificate health across this manufacturer's portfolio.
1434-MDR-012/2026Issued1434-MDR-013/2026Issued1434-MDR-012/2026